20-068 - Study Monitoring the Cognitive(Thinking) Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063)Status: open
A Multicenter, Longitudinal, Open-label, Single-arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod
Patients with Relapsing Multiple Sclerosis
If you have questions about this trial or are interested in participating, please contact this Clinical Trial’s Coordinator by email at email@example.com.
This is a phase 3 clinical trial with ozanimod in relapsing forms of multiple sclerosis. The primary objective is to determine if and how cognition changes when taking ozanimod. This is a 3 year study with approximately 4 visits per year.
SponsorsThis trial is sponsored by Celgene.
Providers Associated With This Trial
- William Kilgo, M.D.NeurologistAssistant Professor of Neurology